Takeda ponies up €130M to settle tax linked to distant AbbVie-Shire breakup fee

Takeda ponies up €130M to settle tax linked to distant AbbVie-Shire breakup fee

Source: 
Fierce Pharma
snippet: 

After years spent challenging a tax break fee tethered to its massive Shire buyout, Takeda has settled with Irish authorities.

Takeda will pay €130 million (about $137 million) to resolve a tax assessment from the Irish Revenue Commissioners, the company said Wednesday. Back in 2018, Irish authorities hit Shire with a €398 million charge tied to AbbVie’s abandoned takeover bid for that company in 2014. Takeda ultimately purchased Shire for $62 billion in 2019.